Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Strides Pharma Science gets USFDA nod for generic anti-bacterial capsules

The company added that the product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals (previously Heritage Pharmaceuticals).

March 04, 2020 / 01:30 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Strides Pharma Science on March 4 said it has received approval from the US health regulator for its generic tetracycline hydrochloride capsules used for treatment of many bacterial infections. The approval granted by the United States Food and Drug Administration (USFDA) to the company's wholly-owned subsidiary, Strides Pharma Global, Singapore, is for multiple strengths of tetracycline hydrochloride capsules of 250 mg and 500 mg, the company said in a statement.

The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals (previously Heritage Pharmaceuticals), it added.

Citing IQVIA MAT data, the company said the US market for tetracycline hydrochloride capsules 250 mg and 500 mg is approximately USD 16 million.

The product will be manufactured at the company's flagship facility at Bengaluru and will be marketed by Strides Pharma in the US market, it said.

Tetracycline hydrochloride capsule is an antibiotic used to treat many different bacterial infections of the skin, intestines, respiratory tract, urinary tract, genitals, lymph nodes, and other body systems, the company added.

In some cases, tetracycline hydrochloride capsule is used when penicillin or another antibiotic cannot be used to treat serious infections such as Anthrax, Listeria, Clostridium, Actinomyces, it said.

Strides Pharma Science said it has 123 cumulative abbreviated new drug application (ANDA) filings with USFDA of which 84 ANDAs have been approved and 39 are pending approval.

PTI

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347